about
Paradoxical antiproliferative effect by a murine mammary tumor-derived epithelial cell lineShedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.A potential oncogenic activity of platelet-derived growth factor d in prostate cancer progressionProstate cancer-associated membrane type 1-matrix metalloproteinase: a pivotal role in bone response and intraosseous tumor growth.Cediranib inhibits both the intraosseous growth of PDGF D-positive prostate cancer cells and the associated bone reactionProstate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover.The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection.Quantitative assessment of small intraosseous prostate cancer burden in SCID mice using fluorescence imaging.Immunohistochemical analysis of Ki-67, p21waf1/cip1 and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial.Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder.Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells.Expression of gelatinase/type IV collagenase in tumor necrosis correlates with cell detachment and tumor invasionTumor necrosis can facilitate the appearance of metastasesMechanism of antimetastatic immunopotentiation by low-dose cyclophosphamideModulation of the antimetastatic effect of a single low dose of cyclophosphamide on rat lymphomaHeterogeneous activation of MMP-9 due to prostate cancer-bone interactionPotent mechanism-based inhibitors for matrix metalloproteinasesThe transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretionInhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitorAntitumoral and antimetastatic effects of metronomic chemotherapy with cyclophosphamide combined with celecoxib on murine mammary adenocarcinomas
P50
Q33301048-DA4991B7-308D-4B10-A38A-9486030BCF62Q33958982-07248C62-F0F4-46AC-A6FE-0A8F7EFED337Q34224640-83A70533-7BDD-4EBB-B33B-09910EE67597Q35855547-F1AAFCB4-B0B9-4F44-8379-E66F7C870501Q36013452-85C112F9-21FA-4191-B6BD-BCB7E359E70EQ36640228-F116B5A6-C0EA-4959-998F-6B4D8D78E777Q36719208-A92F5077-CF1B-401B-B8A4-EDE1851477BEQ37198198-F7B3D127-4599-45AE-BB90-EEBA3D0B4327Q37347935-C5301104-5DC6-445E-903F-955186EA0F62Q38321879-FD708074-2692-4C8E-B433-F5B84DE449B6Q39346450-47772263-E89C-49BB-805C-770F16A1F2E4Q40213930-5A6F6D51-5B0B-46F8-9504-7DBEB68CCA0BQ43742739-6D06BE20-6205-4844-92A5-53A6C4176213Q44243831-7347D958-DDC9-4B7C-8B41-142B93875310Q45858448-C3236097-B1C3-4DEA-B8C4-77C36DAA0DFAQ50103887-FA20BC90-C9E6-4A4D-8455-FD0C4C3B172CQ67488269-C35F82F1-BC92-4114-B37A-7282A32EF9E8Q68273815-923C2ACA-018C-4923-A31F-F925D95A5F9CQ73967013-BFADFC39-7162-40BD-864B-47B2A78C0953Q74256483-0D7A4C6E-62A3-4FAA-997F-C47DAD172314Q80185231-738B6222-DFCC-4651-A73D-AF67D2616C12Q80940021-407D018B-9D86-48D6-8A34-BEFC655A7671Q81019775-2498384F-6229-4487-A8B1-436B190D72D8Q82100283-9DB1D657-1285-4475-90B1-8461A8D6C9DFQ83940496-E9AF1B22-9A8E-4316-A57B-744123D22F76
P50
description
American pathologist
@en
Forscher
@de
chercheur
@fr
investigador
@es
ricercatore
@it
研究者
@zh
name
R D Bonfil
@ast
R D Bonfil
@es
R D Bonfil
@nl
R. Daniel Bonfil
@en
type
label
R D Bonfil
@ast
R D Bonfil
@es
R D Bonfil
@nl
R. Daniel Bonfil
@en
altLabel
R D Bonfil
@en
prefLabel
R D Bonfil
@ast
R D Bonfil
@es
R D Bonfil
@nl
R. Daniel Bonfil
@en
P106
P31
P496
0000-0002-1605-8317